Paterna Salvatore, Parrinello Gaspare, Cannizzaro Sergio, Fasullo Sergio, Torres Daniele, Sarullo Filippo M, Di Pasquale Pietro
Department of Emergency Medicine, University of Palermo, Italy.
Am J Cardiol. 2009 Jan 1;103(1):93-102. doi: 10.1016/j.amjcard.2008.08.043. Epub 2008 Oct 17.
Studies have shown that patients with compensated heart failure (HF) receiving high diuretic doses associated with normal sodium diet and fluid intake restrictions demonstrated significant reductions in readmissions and mortality compared with those who received low-sodium diets, and over a 6-month observation period, a reduction in neurohormonal activation was also observed. The aim of this study was to evaluate the effects of different sodium diets associated with different diuretic doses and different levels of fluid intake on hospital readmissions and neurohormonal changes after 6-month follow-up in patients with compensated HF. Four hundred ten consecutive patients with compensated HF (New York Heart Association class II to IV) aged 53 to 86 years, with ejection fractions <35% and serum creatinine <2 mg/dl, were randomized into 8 groups: group A (n = 52): 1,000 ml/day of fluid intake, 120 mmol/day, and 250 mg furosemide twice daily; group B (n = 51): 1,000 ml/day of fluid intake, 120 mmol/day, and 125 mg furosemide twice daily; group C (n = 51): 1,000 ml/day fluid intake, 80 mmol/day, and 250 mg furosemide twice daily; group D (n = 51): 1,000 ml/day fluid intake, 80 mmol/day, and 125 mg furosemide twice daily; group E (n = 52): 2,000 ml/day fluid intake, 120 mmol/day, and 250 mg furosemide twice daily; group F (n = 50): 2,000 ml/day fluid intake, 120 mmol/day, and 125 mg furosemide twice daily; group G (n = 52): 2,000 ml/day fluid intake, 80 mmol/day, and 250 mg furosemide twice daily; and group H (n = 51): 2,000 ml/day fluid intake, 80 mmol/day, and 125 mg furosemide twice daily. All patients received the treatments >or=30 days after discharge and for 180 days afterward. Signs of HF, body weight, blood pressure, heart rate, laboratory parameters, electrocardiograms, echocardiograms, brain natriuretic peptide, aldosterone, and plasma renin activity were examined at baseline and 180 days later. Group A showed the best results, with a significant reduction (p <0.001) in readmissions, brain natriuretic peptide, aldosterone, and plasma renin activity compared with the other groups during follow-up (p <0.001). In conclusion, these data suggest that the combination of a normal-sodium diet with high diuretic doses and fluid intake restriction, compared with different combinations of sodium diets with more modest fluid intake restrictions and conventional diuretic doses, leads to reductions in readmissions, neurohormonal activation, and renal dysfunction.
研究表明,与正常钠饮食及液体摄入受限相关的高剂量利尿剂治疗的代偿性心力衰竭(HF)患者,与接受低钠饮食的患者相比,再入院率和死亡率显著降低,并且在6个月的观察期内,还观察到神经激素激活有所减少。本研究的目的是评估不同钠饮食与不同利尿剂剂量及不同液体摄入水平对代偿性HF患者6个月随访后的再入院率及神经激素变化的影响。连续纳入410例年龄在53至86岁之间、射血分数<35%且血清肌酐<2mg/dl的代偿性HF患者(纽约心脏协会II至IV级),随机分为8组:A组(n = 52):液体摄入量1000ml/天,120mmol/天,250mg速尿每日两次;B组(n = 51):液体摄入量1000ml/天,120mmol/天,125mg速尿每日两次;C组(n = 51):液体摄入量1000ml/天,80mmol/天,250mg速尿每日两次;D组(n = 51):液体摄入量1000ml/天,80mmol/天,125mg速尿每日两次;E组(n = 52):液体摄入量2000ml/天,120mmol/天,250mg速尿每日两次;F组(n = 50):液体摄入量2000ml/天,120mmol/天,125mg速尿每日两次;G组(n = 52):液体摄入量2000ml/天,80mmol/天,250mg速尿每日两次;H组(n = 51):液体摄入量2000ml/天,80mmol/天,125mg速尿每日两次。所有患者出院后接受治疗≥30天,之后持续180天。在基线及180天后检查HF体征、体重、血压、心率、实验室参数、心电图、超声心动图、脑钠肽、醛固酮及血浆肾素活性。A组显示出最佳结果,与其他组相比,随访期间再入院率、脑钠肽、醛固酮及血浆肾素活性显著降低(p<0.001)。总之,这些数据表明,与钠饮食与更适度的液体摄入限制及常规利尿剂剂量的不同组合相比,正常钠饮食与高剂量利尿剂及液体摄入限制相结合可降低再入院率、神经激素激活及肾功能不全。